ZC3H12A and atherosclerosis: While this reduction in plasma cholesterol levels would definitely have contributed to the reduced atherogenesis, we believe it is not sufficient to explain the dramatic diminishment of atherosclerosis in MCPIP1−/− bone marrow recipients.